Graphic rule for drug metabolism systems
- PMID: 20446902
- DOI: 10.2174/138920010791514261
Graphic rule for drug metabolism systems
Abstract
Using graphic rules to deal with kinetic systems is an elegant approach by combining the graph representation (schematic representation) and rigorous mathematical derivation. It bears the following advantages: (1) providing an intuitive picture or illuminative insights; (2) helping grasp the key points from complicated details; (3) greatly simplifying many tedious, laborious, and error-prone calculations; and (4) able to double-check the final results. In this mini review, the non-steady state graphic rule in enzyme-catalyzed kinetics and protein-folding kinetics was extended to cover drug-metabolic systems. As a demonstration, a step-by-step illustration is presented showing how to use the graphic rule to derive the concentrations of the parent drug and its metabolites vs. time for the seliciclib, vildagliptin, and cyclin-dependent kinase inhibitor (AG-024322) metabolic systems, respectively. It can be seen from these paradigms that the graphic rule is particularly useful to analyze complicated drug metabolic systems and ensure the correctness of the derived results. Meanwhile, the intuitive feature of graphic representation may facilitate analyzing and classifying drug metabolic systems; e.g., according to their directed graphs, the metabolism of seliciclib and the metabolism of vildagliptin can be categorized as 0-->5 mechanism while that of AG-024322 as 0-->4-->3 mechanism.
Similar articles
-
Applications of graph theory to enzyme kinetics and protein folding kinetics. Steady and non-steady-state systems.Biophys Chem. 1990 Jan;35(1):1-24. doi: 10.1016/0301-4622(90)80056-d. Biophys Chem. 1990. PMID: 2183882 Review.
-
Graphic rules in steady and non-steady state enzyme kinetics.J Biol Chem. 1989 Jul 15;264(20):12074-9. J Biol Chem. 1989. PMID: 2745429
-
Human nitrilase-like protein does not catalyze the hydrolysis of vildagliptin.Drug Metab Pharmacokinet. 2014;29(6):463-9. doi: 10.2133/dmpk.DMPK-14-RG-027. Epub 2014 Jul 8. Drug Metab Pharmacokinet. 2014. PMID: 25008847
-
Target-mediated metabolism and target-mediated drug disposition of the DPPIV inhibitor AMG 222.Xenobiotica. 2011 Nov;41(11):945-57. doi: 10.3109/00498254.2011.597455. Epub 2011 Aug 25. Xenobiotica. 2011. PMID: 21867423
-
Clinical evidence and mechanistic basis for vildagliptin's action when added to metformin.Diabetes Obes Metab. 2011 Mar;13(3):193-203. doi: 10.1111/j.1463-1326.2010.01321.x. Diabetes Obes Metab. 2011. PMID: 21205107 Review.
Cited by
-
iROS-gPseKNC: Predicting replication origin sites in DNA by incorporating dinucleotide position-specific propensity into general pseudo nucleotide composition.Oncotarget. 2016 Jun 7;7(23):34180-9. doi: 10.18632/oncotarget.9057. Oncotarget. 2016. PMID: 27147572 Free PMC article.
-
iHyd-PseAAC (EPSV): Identifying Hydroxylation Sites in Proteins by Extracting Enhanced Position and Sequence Variant Feature via Chou's 5-Step Rule and General Pseudo Amino Acid Composition.Curr Genomics. 2019 Feb;20(2):124-133. doi: 10.2174/1389202920666190325162307. Curr Genomics. 2019. PMID: 31555063 Free PMC article.
-
Self-similarity analysis of eubacteria genome based on weighted graph.J Theor Biol. 2011 Jul 7;280(1):10-8. doi: 10.1016/j.jtbi.2011.03.033. Epub 2011 Apr 8. J Theor Biol. 2011. PMID: 21496459 Free PMC article.
-
Biophysical and computational methods to analyze amino acid interaction networks in proteins.Comput Struct Biotechnol J. 2016 Jun 22;14:245-51. doi: 10.1016/j.csbj.2016.06.002. eCollection 2016. Comput Struct Biotechnol J. 2016. PMID: 27441044 Free PMC article. Review.
-
Signal propagation in protein interaction network during colorectal cancer progression.Biomed Res Int. 2013;2013:287019. doi: 10.1155/2013/287019. Epub 2013 Mar 20. Biomed Res Int. 2013. PMID: 23586028 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials